Method

MethodMethod
Method

Method

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

Website
DR 02021InactiveSan Francisco, United States
Rate
Advertise here

About

Method AI is developing a novel surgical navigation platform that leverages continuous 3D ultrasound imaging and AI-driven algorithms. This technology creates subsurface maps and surgical plans to guide physicians during procedures, with the goal of improving cancer-free survival rates and reducing healthcare costs.
Frequently asked

What does Method do?

Method AI is developing a novel surgical navigation platform that leverages continuous 3D ultrasound imaging and AI-driven algorithms. This technology creates subsurface maps and surgical plans to guide physicians during procedures, with the goal of improving cancer-free survival rates and reducing healthcare costs.

What is Method's revenue?

StartupHub estimates Method's annual revenue at $1.1M (range $866K to $1.1M, 27% confidence), based on comparable companies in the sector.

What is Method's valuation?

StartupHub estimates Method's effective valuation at $81.0M (range $50.0M to $120.0M, 18% confidence), based on comparable companies in the sector.

How much funding has Method raised?

Method has raised a total of $20M in funding. The most recent round on record is Series A.

Where is Method headquartered?

Method is headquartered in San Francisco, United States.

When was Method founded?

Method was founded in 2021.

What industry does Method operate in?

Method operates in MedTech, HealthTech, Surgical Robotics, AI-Driven Drug Discovery, Computer Vision, 3D Imaging.

What is Method's current status?

Method's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.